COMMUNIQUÉS West-GlobeNewswire

Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45
30/07/2024
TX45 is an Fc-relaxin fusion protein being evaluated in patients with Group 2 Pulmonary Hypertension (PH) due to Heart Failure with Preserved Ejection Fraction (HFpEF), a serious condition estimated to affect over 600, [...]
Replimune to Present at Two Upcoming Investor Conferences
30/07/2024
WOBURN, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies, today announced [...]
Dyadic to Report Second Quarter 2024 Financial Results on Tuesday, August 13, 2024
30/07/2024
JUPITER, Fla., July 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of [...]
Pacira BioSciences Reports Second Quarter 2024 Financial Results
30/07/2024
-- Conference call today at 4:30 p.m. ET -- TAMPA, Fla., July 30, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative [...]
ADvantage Therapeutics Announces Breakthrough Findings in Alzheimer's Disease Treatment: AD04TM shows immediate symptomatic and disease-modifying properties
30/07/2024
PHILADELPHIA, July 30, 2024 (GLOBE NEWSWIRE) -- ADvantage Therapeutics today announced groundbreaking results from a study on AD04™, a novel therapeutic candidate for Alzheimer's disease. Scientists from ADvantage [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 30 - 2024
30/07/2024
Aggregated presentation by day and by market Purchases of own shares from July 22th to 26th, 2024 Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 30 - 2024
30/07/2024
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 22 au 26 juillet 2024 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
H1 2024 Results - Focus-27 strategic plan on track with timely execution of the operational roadmap
30/07/2024
Press Release Paris, 30th July 2024 Net Sales down 9.6% year-on-year – Core EBITDA margin at 10.6% Accelerated commercial momentum with clients other than Sanofi, with Net Sales up 2.9%, excluding the Brindisi site, [...]
RESULTATS DU PREMIER SEMESTRE 2024 - Le plan stratégique Focus-27 est en bonne voie avec une exécution dans les délais de la feuille de route opérationnelle
30/07/2024
COMMUNIQUE DE PRESSE Paris, le 30 juillet 2024 Chiffre d’affaires en baisse de 9,6 % en variation annuelle - Marge de Core EBITDA de 10,6% Accélération de la dynamique commerciale avec les clients autres que Sanofi, [...]
La Croix-Rouge canadienne annonce une aide financière pour les personnes évacuées de Jasper en raison des feux de forêt en Alberta
30/07/2024
Les ménages contraints d’évacuer leur résidence principale à Jasper recevront 750 $ OTTAWA, Ontario, 30 juill. 2024 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne a annoncé aujourd’hui qu’elle versera un montant unique [...]
BioPorto Announces NIH-Funded Study to Explore the Ability of Renal Biomarkers in Predicting Severe AKI, Advancing Beyond NLP-based AI Algorithms
30/07/2024
July 30, 2024 News Release BioPorto Announces NIH-Funded Study to Explore the Ability of Renal Biomarkers in Predicting Severe AKI, Advancing Beyond NLP-based AI Algorithms ADLM 2024 Conference – Chicago, July 30, 2024 [...]
Ostomy Care Brand Revel Launches Groundbreaking Deodorizing Lubricant
30/07/2024
The Brand’s Debut Product Offers Cutting-edge Technology For Pancaking Prevention and Cleaner Pouch Empties Woburn, MA, July 30, 2024 (GLOBE NEWSWIRE) -- Revel, a pioneering brand in ostomy care, has launched its first [...]
KabaFusion Selected by GC Biopharma USA, Inc. as a Limited Distribution Partner for Partner of ALYGLO™ for Adults With Primary Humoral Immunodeficiency (PI)
30/07/2024
CERRITOS, Calif. and LEXINGTON, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in home infusion, has been selected by GC Biopharma USA, Inc. as a limited distribution partner to [...]
AMN Healthcare Introduces Televate™ Teletherapy Platform for Students K-12
30/07/2024
New Technology to Expand Access to Therapy in High-Need Areas DALLAS, July 30, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare, the nation’s leading healthcare workforce solutions company, is introducing a new teletherapy [...]
Texicare Selects CirrusMD to Provide Access to On-Demand Virtual Care for Small Employer Groups in Texas
30/07/2024
CirrusMD's comprehensive virtual care solution addresses primary, acute, behavioral health and chronic healthcare needs DENVER, July 30, 2024 (GLOBE NEWSWIRE) -- CirrusMD, creator of the Physician-first Care & [...]
Acentra Health Honored as an AWS Champion for Digital Transformation in the Public Health Sector
30/07/2024
Company is the only public health sector-focused technology partner recognized for its use of cloud-native solutions to improve efficiency and outcomes MCLEAN, Va., July 30, 2024 (GLOBE NEWSWIRE) -- Acentra Health , a [...]
Marius Pharmaceuticals Submits KYZATREX® (Testosterone Undecanoate) CIII Capsules for Approval to Health Canada
30/07/2024
RALEIGH, N.C., July 30, 2024 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals , a patient-centric healthcare company focused on developing innovative therapies for Testosterone Deficiency, is pleased to announce the [...]
Sanara MedTech Inc. Announces Second Quarter Earnings Release and Conference Call Dates
30/07/2024
FORT WORTH, TX, July 30, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused [...]
Outlook Therapeutics® to Present at the BTIG Virtual Biotechnology Conference 2024
30/07/2024
Company to participate in a fireside chat on Monday, August 5 th at 8:00 AM ET ISELIN, N.J., July 30, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on [...]

Pages